Merck, Ridgeback to supply 1.75 million molnupiravir courses to UK

Merck aims to produce 10 million courses of molnupiravir by the end of this year. Credit: 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.